NXGL
NEXGEL, Inc.
There isn't enough reported data to score NXGL yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
NXGL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
NXGL's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
NXGL PE Valuation
NXGL has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
NXGL Forward outlook
There aren't enough analyst estimates for NXGL to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
NXGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$14.20 | -$6.20 |
| Q1 2026 | -$8.00 | +$1.00 |
| Q4 2025 | -$7.60 | +$2.40 |
| Q3 2025 | -$7.40 | +$4.20 |
| Q2 2025 | -$8.00 | +$3.40 |
| Q1 2025 | -$9.00 | +$2.00 |
| Q4 2024 | -$10.00 | +$1.20 |
| Q3 2024 | -$11.60 | -$2.00 |
NXGL is still losing money, but far less than before: $14.20 per share over the past year, against $43.20 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over NXGL on earnings quality, reporting a profit while its opponent remains loss making.
NXGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.7M | +28% |
| Q1 2026 | $2.7M | -5.6% |
| Q4 2025 | $2.8M | -8.1% |
| Q3 2025 | $2.9M | -0.2% |
| Q2 2025 | $2.9M | +100% |
| Q1 2025 | $2.8M | +122% |
| Q4 2024 | $3M | +181% |
| Q3 2024 | $2.9M | +141% |
NXGL's revenue has held roughly level: $4M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -68% | -46 points |
| Q1 2026 | -36% | -8.5 points |
| Q4 2025 | -43% | -16 points |
| Q3 2025 | -25% | +2.1 points |
| Q2 2025 | -22% | +51 points |
| Q1 2025 | -28% | +41 points |
| Q4 2024 | -28% | +85 points |
| Q3 2024 | -27% | +23 points |
NXGL's operating margin was −68% last quarter, down 46 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over NXGL on profitability, with a higher operating margin.
NXGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $241K | +$1.2M |
| Q3 2025 | -$793K | +$436K |
| Q4 2024 | -$928K | -$256K |
| Q3 2024 | -$1.2M | -$148K |
| Q2 2024 | -$909K | +$473K |
| Q1 2024 | -$1.2M | -$447K |
| Q4 2023 | -$672K | -$15K |
| Q3 2023 | -$1.1M | -$176K |
UNH has the stronger cash trend. Its trailing FCF is up 5.2% versus its history, compared with NXGL at up 0.1%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
NXGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.9% | +40.5K shares |
| 1 year | +18% | +67.9K shares |
| 3 years | +62% | +172K shares |
NXGL has 450,663 diluted shares, up 18% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over NXGL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
NXGL Net Leverage
NXGL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
NXGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.8 | Neutral |
| Stochastic | 7.2 | Oversold |
NXGL's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
NXGL PE vs Healthcare Sector
NXGL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
NXGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.06 | 6.7% below |
| 20 week MA | $6.53 | 42% below |
| 50 week MA | $14.7 | 74% below |
| 100 week MA | $34.7 | 89% below |
| 200 week MA | $39.9 | 90% below |
NXGL is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over NXGL on trend strength, trading above more of its moving averages.
NXGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $62.4 | $62.4 | 0% |
| 2022 | $62.4 | $27.2 | -56% |
| 2023 | $27.2 | $42.6 | +57% |
| 2024 | $42.6 | $94.0 | +121% |
| 2025 | $94.0 | $30.6 | -67% |
| 2026 YTD | $30.6 | $3.79 | -88% |
NXGL's yearly returns have swung widely, from +121% in 2024 to −67% in 2025. It's down 88% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over NXGL on returns for 2026, with the stronger performance.